Blocking the IL-6-STAT3 signaling pathway by CN-encapsulated probiotics prevented the prevention of colitis-associated colorectal cancer was achieved, which further confirmed the pathogenic role of STAT3 in colitis-associated colorectal cancer (Song et al. 2021). The gene discussed is STAT3; the disease is colitis.